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Abstract
Drawing from evidence from epidemiology and exposure assessment studies and 
recommendations from expert practice, we describe a process to guide healthcare providers 
helping their patients who present with symptoms that might be associated with living in damp 
housing. We present the procedure in the form of a guided two-part interview. The first part has 
five questions that triage the patient towards a more detailed questionnaire that reflects features of 
housing conditions known to be reliably associated with exposures to mold and dampness 
contaminants. We chose the questions based upon conditions associated with moisture problems in 
homes across the United States and Canada. The goal is to facilitate the clinician’s effort to help 
patients reduce exposure to environmental triggers that elicit symptoms in order to better manage 
their disease.
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In 2004 the Institute of Medicine’s Committee on Damp Indoor Spaces and Health 
conducted a comprehensive literature review and concluded that there was sufficient 
evidence of an association between damp indoor environments and persistent upper 
respiratory tract symptoms, namely cough, wheeze, and asthma in persons with allergic 
sensitization to fungi1. Subsequent epidemiologic and mechanistic studies have refined and 
extended these findings 2–4. For the epidemiology research discussed here, dampness has 
been most commonly associated with the simultaneous occurrence of three factors: visible 
water damage or stains, visible mold, and odors from microbial growth 2. The American 
Society of Heating, Refrigeration, and Air Conditioning (ASHRAE) concluded “that the 
presence of all three factors is therefore useful as an interim definition for a damp 
building”5.
The air in a clean and dry building contains spores and spore- and mycelial fragments of the 
fungi present in outdoor air 6, 7 as well other outdoor air contaminants 8. Fungal spores and 
fragments can enter the living space of a building from the outside air through intentional 
openings in the building envelope such as open windows and doors, as well as fresh air 
intakes of forced air ventilation systems on commercial buildings. Importantly, exposures to 
fungi in outdoor air are associated with significant impacts on asthma 9. Fungal growth 
inside of a building envelope tends to occur in micro-environments containing nutrients and 
moisture sufficient for spore germination leading to subsequent growth into colonies and 
eventual generation of additional spores and hyphae. This is known as colonization, and 
applies to actively growing colonies (i.e., fungal growth) and dormant or dead colonies (also 
fungal growth). The more fungal growth in a building the greater the proportion of spore-and 
mycelial fragments compared to intact spores in the air 10, 11.
Using a weight of evidence approach, three recent reviews considering the implementation 
of interventions combining elimination of moisture intrusion and removal of moldy items 
concluded that comprehensive remediation measures reduce fungal exposure and 
consequently respiratory symptoms and asthma morbidity 2, 3, 12. However, as with reviews 
of other environmental allergens (such as dust mites, rodents and cockroaches), none have 
shown that asthma development can be prevented by reducing these exposures 13–15. 
Nonetheless, the position that prevention or remediation of fungal growth indoors can reduce 
respiratory disease symptoms has been adopted by several prominent panels and health 
agencies 1, 4, 16, 17. This is an important public health issue in that the maximum attributable 
risk for asthma associated with fungi and dampness has been estimated at 20% 18, 19.
The intent of this review is to discuss fungi and dampness inside buildings and provide 
evidence-based questions useful to determine when home visits are warranted to assess 
potential fungal exposure. Ultimately the goal is to reduce exposure to fungi and fungal 
products from growth inside the building.
Provider-Facilitated Home Assessment
While many issues related to fungi and dampness can be managed by the patient with the 
guidance of a healthcare professional, there are situations where consultation with a trained 
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indoor environment professional (IEP) is necessary. However, it is not practical or necessary 
for all patients to have such an assessment. Recognizing that assessments are inconvenient 
for the occupant, currently expensive, and may be unnecessary or inconclusive, what is 
needed are criteria for determining which patients and which homes would most likely 
benefit from a home assessment.
Since the evidence above indicates that patients who have respiratory illnesses (e.g., asthma, 
rhinitis) are at increased risk of developing symptoms from exposure to fungal growth and 
dampness, such individuals might benefit from a home assessment if increased exposure to 
fungal growth is suspected. Other considerations for a home assessment include the 
following:
• Has the patient lived in the home long enough for respiratory symptoms to 
occur in response to indoor fungal exposure? The biologically-relevant 
time period for exposure to occur and lead to many types of symptoms or 
disease onset is not known. A history of increased symptoms following 
occupancy of a home would be evidence of a relevant exposure.
• Is the patient likely to occupy the home for long enough to justify the 
assessment? If the patient plans to move to another home in the near 
future, an assessment might not be justified.
• Does the patient have enough control of the environment to implement 
interventions (i.e., remediate or otherwise change the occupied space) if 
necessary? While it may help to understand what indoor exposures are 
present, such knowledge is less useful if interventions cannot be 
performed easily as may be the case for a rental unit or subsidized 
housing. However, evidence of significant exposure might encourage the 
landlord to perform necessary interventions or the patient to move to a 
different home.
Tools to determine if a home assessment is warranted for fungi and dampness
In cases where possible fungal related illness is reported, a two-step process (Part A and B 
described below) is recommended to decide whether or not there is justification for a 
building assessment focused on moisture / fungal growth issues. The first step is for 
clinicians to consider asking key questions to determine whether the common facilitative 
factors associated with environmental exposure to moisture and fungal growth may be 
present 20 Part A (shown in Figure 1) includes five (5) questions for the clinician (or 
designate) to administer to a patient with confirmed symptoms that are consistent with an 
increased likelihood of exposure to fungal growth. They are not specific to fungal exposure, 
so dust mites and other relevant allergens should also be considered 13–15. A positive reply 
to all five questions in Part A is sufficient indication for the need of a home assessment. 
However, ANY one of these indicators may justify the application of Part B (shown in 
Figure 2) by an allied health professional (or designate) in order to aid in the decision 
whether or not to recommend a home assessment for the patient. A majority of answers in 
the red section of Part B (i.e., first column) indicates that a home assessment might be 
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helpful to understand potential sources of dampness and pathways of exposure to fungal 
growth.
Rationale for including the five questions in Part A
The first four questions have been used in several epidemiologic studies of allergy and 
asthma over the years1, 3, 4, 21. However, many of the questions were often considered for 
proxies of other allergen exposures that can occur in damp buildings, namely those from 
dust mite allergens 22, 23. Therefore, in order to assess associations between dampness 
characteristics with fungal levels in the indoor environment, studies have incorporated one or 
more types of fungal measurement including culture (to identify and quantify propagules), 
spore counts (include viable and nonviable spores), fungal cell components (e.g., glucan, 
ergosterol), and molecular methods such as next generation sequencing). The fifth question 
is more recent and reflects increased interest in major flooding events. Furnishings (visibly 
moldy or otherwise) that are transported into a new home could serve as a source of 
biologically-relevant exposure (via spores, fungal fragments), even when a new home is 
relatively dry.
Each of the epidemiology and exposure assessment studies used different variations of these 
first four fungi/dampness questions, so we sought to find questions that were standardized 
and had been cognitively tested for comprehension. Therefore, we chose questions that have 
been used in the American Housing Survey (AHS). The U.S. Census Bureau conducts the 
AHS every two years in order to assess the quality of housing in the United States. AHS is a 
national representative survey that collects data on an average of 55,000 U.S. housing units, 
including apartments, single-family homes, and mobile homes. The methodology of this 
survey has been described in more detail elsewhere24.
When an AHS question was not available, we focused on the most commonly-used and 
plainly-written versions of questions that were used in peer-reviewed epidemiology and 
exposure assessment studies.
Here is a detailed explanation for each of those five questions
1. During the past 12 months, have there been water problems or dampness in your 
home from broken pipes, leaks, heavy rain, or floods?: Water damage has been 
associated with both high fungal concentrations in homes and with asthma symptoms. In the 
IOM report 1, the tables on pages 60–65 contain a comprehensive list of exposure studies 
that have seen associations between water damage and higher levels of fungi. In the WHO 
report 4, water damage was associated with asthma symptoms.
2. In the last 12 months, how often have you noticed any moldy/musty smells inside 
your home?: Mold odor has been associated with both fungal concentrations in homes as 
well as with asthma symptoms. In a prospective birth cohort study, one of the strongest 
associations was between mold odor and development of childhood asthma (OR = 2.44, 
95% CI= 1.07-5.88) 25. In the WHO report 4 and a recent meta-analysis 3,, mold odor also 
was associated with development of asthma. These authors further state that water damage 
per se was not associated with increased risk of developing asthma because water damage 
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itself is not the etiologic agent. Rather, water-damaged materials or furnishings (if not 
remediated promptly) can lead to microbial products or dust mite exposure. Mold odor is 
associated with increased concentrations of viable fungi 26 and of fungal glucan loadings in 
settled dust 27. In a more recent study, mold odor was also found to be strongly associated 
with total culturable fungi in air samples (OR = 3.48, 95% CI= 1.13-11.6) 28.Therefore, 
mold odor is a reliable sign of water damage and fungal growth that suggests a continuous 
source of exposure to fungal particulates.
3. In the last 12 months, was there fungal growth covering an area greater than or 
equal to the size of an 8" × 11" piece of paper in your home?: Visible fungal growth has 
been associated with both elevated fungal concentrations in homes as well as with asthma 
symptoms. In the WHO report 4, water damage was considered an asthma trigger and a 
recent meta-analysis 3 considered visible fungal growth as an agent in the causal pathway (of 
fungal-related agents) to asthma development.
4. In the past 12 months, have you noticed condensation on windows in your home?: 
Not as many studies have used resident-reported condensation on windows as a proxy for 
fungal exposure or fungi-related asthma symptoms. An early Danish study found that fungal 
levels in house dust samples were strongly associated with “window vapor” 29. Because of 
the small sample size (n=57 homes), the association did not reach statistical significance 
(OR=3.1, 95%CI = 0.9-10.8). In a meta-analysis of birth cohort studies 21, the exact wording 
of a condensation question was provided in an online supplemental table, “In your child’s 
bedroom, during the winter months, does condensation ever form on the walls?” The 
Leicester study was one of the birth cohorts in the meta-analysis which found an increased 
risk of visible mold/dampness and childhood allergic respiratory symptoms30. Therefore, we 
used a combination of the questions from both the Danish study and the Leicester study to 
formulate our window condensation question. We speculate that residents might not be able 
to see water vapor condensing on hidden surfaces (e.g., behind furniture, behind paintings 
hanging on the indoor side of exterior walls), but they might be able to at least see the water 
vapor on windows. The question in the Health Canada questionnaires for housing and health 
studies is similar to that in the UK study noted above11, 27.
5. Have any of your furnishings, clothes, possessions been in a building that had water 
damage?: This last question was developed by the current authors. We have not seen it used 
previously; however, given studies from major flood events (e.g., Mississippi floods 1993, 
Hurricane Katrina 2005, and Iowa floods 2008), this question will prompt the clinician to the 
potential for belongings which might pose a risk to continued and/or new fungal 
growth 31–33. Also, removal of colonized building materials (a common part of remediation 
activities) can generate fungal-contaminated dust. This dust can accumulate on unprotected 
contents remaining in the building. Given sufficient moisture, such belongings could have 
visible or hidden fungal growth.
Rationale for including the questions in Part B
Part B includes additional questions for the clinician (or designate) to administer to a patient 
to aid in the decision of whether or not to recommend a home assessment for the patient. 
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The selection of these questions was based upon epidemiologic studies as well as purely 
exposure assessment studies 21, 27, 29, 34–36. Several studies often had housing stock that was 
unique to their locality, so questions such as “How do you heat your home?” might be 
relevant for that one location but not for others.
Crawlspaces and basements—Poorly designed or maintained crawl spaces and 
basements can result in dampness and hidden fungal damage that affects the occupied space.
Heating, Ventilation and Cooling—The use of wood stoves or fireplaces is a risk factor 
for increased fungal growth for a number of reasons including excess storage of wood 
indoors. Like wood stoves and fireplaces, the use of a space heater overheats one room 
which can result in other rooms being too cool and thus increasing the risk of condensation. 
For homes in warmer climates, condensation can also be a problem. Without a home 
assessment, it is difficult to determine if air conditioning is helping to decrease humidity or 
adding to fungi and dampness problems. Common in some parts of the country, evaporative 
coolers are especially difficult to maintain properly without increasing relative humidity 
(RH) which can foster fungal growth.
Some occupant activities such as showering, cooking, and washing clothes can release large 
amounts of water into the air. Exhaust fans that are properly maintained and vent to the 
outdoors have the ability to quickly reduce humidity levels. If the exhaust fans are absent, do 
not work or do not vent outside, conditions of localized high humidity can develop and 
produce greater risk for condensation and fungal damage.
Dust reservoirs—Dust and lint that gathers in carpets is hygroscopic. This means that like 
salt or sugar they are prone to absorbing moisture in damp environments. If the relative 
humidity rises above 85% at floor surface level (within a few millimeters), dust can gain 
enough moisture to support the growth of some fungi 37. A simple and effective action to 
mitigate this problem is to reduce the dust burdens in carpets and soft furniture by thorough 
cleaning with a vacuum cleaner equipped with a HEPA filter. A study conducted in 
Canadian homes has shown that it might take 4-6 methodical cleanings to reduce the fine 
dust burden in carpeting. However, this has many benefits other than just reducing potential 
exposure to dust mite allergens (another indoor allergy/asthma trigger related to 
dampness)36.
Humidification and Dehumidification—When most residents use a dehumidifier, this 
is clearly an indication that the home has a dampness problem. The use of a dehumidifier 
shows positive corrective steps by the resident. Even so, a home assessment may still be 
warranted to identify the source of the moisture and determine whether or not the 
dehumidifier is sufficient (i.e., proper size and maintenance) for controlling moisture in the 
structure or if other steps may be needed to mitigate any potential fungal growth problem 
(e.g., hidden fungal damage in wall cavities) that occurred before use of the dehumidifier. 
Conversely, using a humidifier to add moisture to the air indicates that the home is perceived 
as dry. Nonetheless, humidifiers add moisture that can condense at cold surfaces and they 
result in the aerosolization of bacteria and fungi if not properly cleaned and maintained.
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The Home Assessment Process
Once it is determined that a home assessment is required, a good working relationship 
between the healthcare provider and the IEP is important. The IEP should be careful not to 
comment on health effects from potential mold exposures, yet should be able to convey the 
“health” of the home to the healthcare provider in a clear manner. Likewise, the clinician 
might not be able to grade the “health” of the home unless the clinician understands 
construction, moisture behavior in building materials and the complexities of sampling and 
analysis for surface or airborne fungal materials. Similar to the activity of administering the 
home assessment tool (Part A and B), an actual home assessment might need repetition. A 
good assessment report will drive any remediation activities (if necessary) and can also 
provide insight for the healthcare provider to improve the management of their patients’ 
respiratory disease symptoms. Details of IEP selection, home assessments, and assessment 
reports are described in the Appendix.
Conclusions
The main objective of this manuscript was to help healthcare professionals determine when a 
home visit might be helpful to assess fungal exposure. The two-part tool for mold/dampness-
associated home assessment determination contains many evidence-based questions which 
are supported by peer-reviewed literature. Given that homes are a dynamic environment, the 
process might need to be repeated depending upon circumstances in the home (e.g., flooding 
events, seasonal variation, and renovations to the home). Changing characteristics of the 
occupants (e.g., new pets, number of residents, changes in showering, cooking, or cleaning 
habits) can also affect fungi and dampness, so these should be considered by the healthcare 
provider too.
As homes become more complex environments, the home assessment determination tool 
(Part A and B) should evolve too. For now, this tool is based upon peer-reviewed literature 
and professional opinion of building scientists, environmental mycologists, exposure 
assessment scientists, environmental epidemiologists, immunologists who specialize in 
fungi, and physicians who specialize in asthma. However, advances in each of these fields 
occur every year and these advances will certainly improve our ability to recognize, 
evaluate, and control dampness and fungal exposure in the home in meaningful ways that 
will hopefully decrease the burden of respiratory disease for the occupants.
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List of Abbreviations
AHS American Housing Survey
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HEPA High-efficiency Particulate Arresting
IEP Indoor Environment Professional
IOM Institute of Medicine
WHO World Health Organization
OR Odds Ratio
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Key introductory questions to determine whether the mold or dampness may be present
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Comprehensive questions to determine whether the mold or dampness may be present
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